BridgeMD
New treatment option for Intracranial Aneurysm
Official title Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia
ClinicalTrials.gov ID: NCT06400940
What this study is testing
What is ticagrelor (tablets, 180 mg) or prasugrel (tablets, 10 mg).?
ticagrelor (tablets, 180 mg) or prasugrel (tablets, 10 mg). is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for intracranial aneurysm.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Prospective, post-registration, interventional, randomized, in parallel groups, multicenter Eurasian clinical study of DERIVO®/DERIVO® mini Aneurysm Embolization Device, Europe-Asia
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- localization and structure of the aneurysm allows the use of a DERIVO®/DERIVO® mini flow-diverting stent for treatment;
- the aneurysm cannot be cured by other methods of endovascular therapy, or there is a higher risk of complications when using other methods of...
- clipping or embolization with spirals (if performed earlier) led to a recurrence of the aneurysm.
You likely can't join if
- Age less than 18 years.
- Pregnancy.
- The presence of a previously implanted stent in a cerebral artery.
- Dissection of cerebral or peripheral vessels.
- The presence of contraindications to the use of the DERIVO®/DERIVO® mini medical device, specified in the instructions for use:
- non-compliance of the aneurysm and/or the carrier vessel with the indications for the use of the device;
See the full eligibility criteria
- localization and structure of the aneurysm allows the use of a DERIVO®/DERIVO® mini flow-diverting stent for treatment;
- the aneurysm cannot be cured by other methods of endovascular therapy, or there is a higher risk of complications when using other methods of endovascular therapy or microsurgery;
- clipping or embolization with spirals (if performed earlier) led to a recurrence of the aneurysm.
- Age less than 18 years.
- Pregnancy.
- The presence of a previously implanted stent in a cerebral artery.
- Dissection of cerebral or peripheral vessels.
- The presence of contraindications to the use of the DERIVO®/DERIVO® mini medical device, specified in the instructions for use:
- non-compliance of the aneurysm and/or the carrier vessel with the indications for the use of the device;
- non-physiological structure of cerebral vessels;
- vascular disorders that are a contraindication to endovascular interventions.
- The presence of contraindications for antiplatelet (antithrombotic) and/or anticoagulant therapy in accordance with the instructions for the medical use of drugs.
The study team makes the final eligibility decision.
Where it's taking place
- Saint Petersburg, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint Petersburg, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.